{"entity":{"id":"2035","kind":"year","name":"2035 in oncology","aka":["2035"],"tldr":"Everything OnCo dates to 2035: 1 entry, 1 expected date. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.","summary":"1 dated entry in OnCo fall in 2035: 1 expected date.\n\nOf those, 1 to the day. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.\n\nEverything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.","asOf":"2026-09-25","links":[],"tags":[],"related":["2034","2036"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Generated from every dated field in the corpus, not written by hand. The groups and the fields behind them are listed in src/lib/year-groups.ts; the reader is src/lib/years.ts."],"year":2035,"events":[{"group":"expected","date":"2035-11-02","precision":"day","title":"A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnose: primary...","note":"Estimated primary completion date on ClinicalTrials.gov.","from":"nct05828511","refs":[]}]},"route":"/years/2035/","neighbours":{"year":[{"id":"2034","kind":"year","name":"2034 in oncology","route":"/years/2034/"},{"id":"2036","kind":"year","name":"2036 in oncology","route":"/years/2036/"}]}}